EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical

Interview with Lawrence Friedhoff of Axovant Sciences

JCS speaks with Lawrence Friedhoff, the Chief Development Officer of Axovant Sciences, about his involvement with the development of Donepezil, the most widely-used drug for the treatment of Alzheimer’s.

Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18